Eurofins Consumer Product Testing Announces State-of-the-Art Expansion of Bangalore Laboratory
BANGALORE, India--(BUSINESS WIRE)--The Eurofins Consumer Product Testing network of laboratories in India recently unveiled its expanded, state-of-the-art facilities in Hongasandra, Bangalore. This strategic investment doubles the Bangalore laboratory's footprint and offers enhanced capabilities, enabling a significant leap in compliance and performance testing tailored to the evolving needs of India's textile, apparel, footwear, and leather goods markets. The expansion directly addresses the growing demand for a one-stop solution for comprehensive quality, safety, and sustainability testing services across India's rapidly advancing manufacturing supply chain landscape.
The Eurofins Consumer Product Testing network of laboratories in India is a trusted partner for global and domestic brands, retailers, and manufacturers. With these new upgrades, the Bangalore laboratory is well-positioned provide innovative and specialised testing services, including:
Chemical Smart Testing to provide comprehensive restricted substances list (RSL) analysis for global market compliance;
Advanced Dry Cleaning Testing Capabilities to ensure textile durability and performance across multiple cleaning methods;
Comprehensive testing for JIS Standards, in collaboration with KAKEN TEST CENTRE, Japan, reinforcing support to Japanese buyers' compliance requirements.
With a modern layout, a compliance-first design, and a LEAN-aligned workflow, the enhanced laboratory streamlines operations and delivers a seamless service to clients. Dedicated spaces for innovation and future growth reflect the Eurofins Consumer Product Testing network of laboratories' commitment to advancing India's dynamic consumer product ecosystem, meeting future market demands, and offering testing expertise to meet the highest standards.
Backed by a global network of over 85 laboratories and more than 4,000 employees worldwide, the Eurofins network of Consumer Product Testing laboratories provides global clients with a wide array of industry leading testing services across Softlines & Hardlines (S&H), Cosmetics & Personal Care (C&PC), Electrical & Electronics (E&E), and Sustainability Services.
About Eurofins Consumer Product Testing
Backed by a global network of over 85 laboratories and more than 4,000 employees worldwide, the Eurofins Consumer Product Testing network of laboratories provides global clients with a wide array of industry-leading testing services across the Softlines & Hardlines (S&H), Cosmetics & Personal Care (C&PC), Electrical & Electronics (E&E), and Sustainability Services fields.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Thousands of Convergint Colleagues Revitalize Hundreds of Communities and Increase School Safety Globally for Annual Day of Service
Convergint's 24th Annual Convergint Social Responsibility Day and STEP Up for Schools Initiative Benefit Underserved Communities and Needs of People Around the World SCHAUMBURG, Ill., June 06, 2025--(BUSINESS WIRE)--Today, more than 174 community organizations and 35 schools across 37 countries globally are stronger as nearly 11,000 volunteers from Convergint, a global systems integrator with 220 locations worldwide, volunteered approximately 60,000 hours of their time for the company's 24th annual Convergint Social Responsibility Day. This year's efforts include support from over 30 partners across the industry who also volunteered their time and over $639,000 in donations of goods and services. The day also includes donations of security technology to over 20 schools as part of the organization's STEP Up for Schools initiative — a vital program to create safer learning environments for students and educators across the globe. "We are proud that today, and for nearly a quarter of a century, our colleagues and industry partners come together in just a 24-hour span as a greater force of good to give back to our communities," said Ann Fandozzi, CEO, Convergint. "Helping address unmet needs in the communities where Convergint colleagues and their families reside – including secure, safe educational environments to foster positive experiences for the next generation – is core to our values." In conjunction with Convergint Social Responsibility Day, the company continues its STEP (Secure, Train, Educate, Protect) Up for Schools Initiative to create safer learning environments for students and educators across the globe – a critical effort that supports underserved schools by donating critical security upgrades and hands-on assistance to help meet the unique safety needs of each campus. From installing new intrusion detection and video camera systems to helping with infrastructure improvements and other security and safety services, Convergint teams are working side by side with local partners and educators to build more secure, welcoming spaces where learning can thrive. To date, more than 100 STEP Up projects have been completed by Convergint and its partners, impacting communities globally. STEP Up projects underway around the world this year include: U.S. – Multiple projects across the country in Baltimore, MD; Knoxville, TN; Dallas, TX; Englewood, CO; Nashville, TN; San Diego, CA; and San Francisco, CA. For example, Colorado's Finest High School of Choice, serving over 300 students in Englewood, CO, is receiving 28 new cameras, 15 speakers, vape and aggression sensors, card reader and lockdown technologies. India – Captain Chandan Lal Special Middle School for the Blind in Gurugram is receiving an installation and donation of CCTV systems as well as painting and landscaping refurbishments. Thailand – Wat Sabok Khiao School in Nakhon Nayok will receive installation and donation of a solar pole, providing light source to illuminate the area as most students ride their bicycle to school, and food for 58 students and faculty. While Convergint Social Responsibility Day has an impact around the globe, in the US alone over 5,000 Convergint volunteers came together, spending over 43,000 hours of their time supporting over 90 community organizations. About Convergint Social Responsibility Day and STEP Up for Schools Since 2002, on the first Friday in June, for Convergint Social Responsibility Day (CSRD) the company closes for a full, paid workday so that colleagues can serve in their communities through various service projects. Convergint established its STEP Up for Schools Initiative as part of CSRD to help strengthen school security. Through the program, Convergint provides free safety and security installations, upgrades, and assessments to underserved schools across the globe. These initiatives are aimed at giving back and creating impactful change in communities around the world, and Convergint Social Responsibility Day strives to inspire all colleagues to surpass what they believe is possible. To learn more about Convergint's STEP Up for Schools program and apply, visit: About Convergint Convergint is a $2.6 billion global, industry-leading systems integrator that designs, installs, and services electronic security, cybersecurity, fire and life safety, building automation, and audio-visual systems. Listed as the #1 systems integrator in SDM Magazine's Top Systems Integrators Report for the past 6 years, Convergint leads with over 10,000 colleagues and more than 220 locations worldwide. To learn more about Convergint, visit View source version on Contacts Convergint PRConvergint@ Tommasina Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors MINNEAPOLIS, June 06, 2025--(BUSINESS WIRE)--HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #HOPE4KIDNEY trial is expected to support a future submission for regulatory clearance to expand the use of histotripsy to treat kidney tissue/tumors. The Edison System is the first and only platform to use histotripsy, a non-thermal, non-invasive focused ultrasound technology, to mechanically liquefy tumors without surgery, radiation, or systemic therapies. Unlike invasive surgical approaches, histotripsy does not require incisions and enables real-time imaging and treatment monitoring, allowing physicians to target and control tissue destruction while sparing surrounding structures. "Our vision is for the Edison System to become a foundational, non-invasive solution across a wide range of clinical applications," said Mike Blue, President and CEO, HistoSonics. "Completing enrollment in our pivotal kidney tumor trial represents a significant milestone toward that goal and reinforces our confidence in expanding histotripsy into additional tumor types and indications. This achievement reflects the dedication of our team and clinical partners and brings us closer to transforming the treatment of solid tumors without the need for surgery." Dr. William C. Huang, MD FACS, Professor and Vice Chair of Urology at the NYU Grossman School of Medicine serves as a principal investigator at the NYU Langone Medical Center, the top enrolling site in the trial. Dr. Huang commented, "Histotripsy offers a novel, completely non-invasive treatment paradigm for kidney tumors that precisely images and treats tumors while preserving surrounding critical structures thereby minimizing the morbidity associated with traditional surgical and thermal ablative techniques." Dr. Michael McDonald, Assistant Professor of Urology at the University of Central Florida College of Medicine and Urologic Surgeon at AdventHealth at Celebration Florida, serves as a principal investigator for one of the participating sites in the trial. Dr. McDonald commented, "HistoSonics represents a paradigm shift proving that the most profound treatments for both benign and malignant diseases need not be the most invasive. The ability to precisely target and destroy tumors without scalpel or scar is the next step in the evolution of non-surgical intervention." The Edison System has not been evaluated for the treatment of any specific disease, including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumour progression, 5-year survival or overall survival). United States Intended Use Statement: The Edison System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by physicians who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions, and a summary of clinical trial results, including reported adverse events. About HistoSonics HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, Michigan and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: For patient-related information please visit: View source version on Contacts Media contacts:Josh KingVice President of 608.332.8124 Kimberly HaKKH Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
40 minutes ago
- Business Wire
Wolfson BTR Breaks Ground on Symphony Lakes, a 274-Unit Build-to-Rent Community in the Tampa-Sarasota Corridor
SARASOTA, Fla.--(BUSINESS WIRE)--Wolfson BTR, Florida's first large-scale Build-to-Rent (BTR) developer, announced it has officially broken ground on April 22, 2025 for their Symphony Lakes, a fully-amenitized 274-unit Build-to-Rent community located strategically between the Sarasota/Bradenton and Tampa/St. Petersburg metropolitan areas. Wolfson BTR Breaks Ground on Symphony Lakes A 274-unit BTR community of townhomes and single-family homes with private backyards, garages, and full amenities in the Tampa-Sarasota corridor. Spread across approximately 50 acres, Symphony Lakes is a two-phase development featuring 3- and 4-bedroom townhomes and 4-bedroom detached single-family homes, each with private backyards and attached garages. Phase I will deliver 220 townhomes and 18 single-family homes, while Phase II will bring an additional 54 townhomes to the community. The project will offer a full suite of lifestyle amenities, including a resident clubhouse, fitness center, resort-style pool, playground, meeting spaces, and extensive dog-walking and running trails—all designed to meet the evolving needs of today's renters who seek more space, privacy, and a higher standard of living. 'Symphony Lakes represents our continued commitment to bringing thoughtful, community-driven Build-to-Rent projects to markets that desperately need quality housing options,' said Adam Wolfson, CEO and Founder at Wolfson BTR. 'We are focused on delivering homes and communities that provide a bridge for those who are not yet ready for homeownership but seek a living experience beyond that of traditional multifamily apartments inclusive of more space, privacy, and community connection' Site work formally began in October 2024, with vertical construction scheduled to commence in August 2025. The first units are expected to be delivered beginning in early 2026. Situated within a three-minute drive of I-275, Symphony Lakes offers residents easy connectivity to major employment hubs, retail, dining, and coastal amenities in both the Tampa Bay and Sarasota regions. About Wolfson BTR Company Wolfson BTR is the first large-scale BTR developer in the state of Florida (and one of the first in the Southeastern U.S.) and both a pioneer and award-winning leader in the space. With over 2,000 units valued at more than $1 billion in its pipeline, the company is a fundamentals-driven real estate investor, developer, and fund manager focused on delivering asymmetric, outsized risk-adjusted returns for its investors. Backed by its internal discretionary real estate fund, the Plain Sight Properties ResiFund series, Wolfson BTR has been fully committed to the BTR model since 2017. The company is focused on long-term solutions to the nation's multi-generational housing shortage, with an emphasis on quality, community, and responsible development.
